ABUS Quote, Trading Chart, Arbutus Biopharma Corporation
home / stock / abus / abus quote
$3.29 Last:
3.13% Change Percent:
$3.24 Open:
$3.29 Previous Close:
$3.56 High:
$3.24 Low:
3,038,365 Volume:
06/24/2021 04:41:30 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
ABUS Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-24 | 3.24 | 3.29 | 3.56 | 3.24 | 3,038,365 |
| 2021-06-23 | 3.12 | 3.19 | 3.24 | 3.095 | 1,015,146 |
| 2021-06-22 | 3.17 | 3.1 | 3.175 | 3.04 | 1,376,398 |
| 2021-06-21 | 3.26 | 3.15 | 3.28 | 3.13 | 1,062,519 |
| 2021-06-18 | 3.23 | 3.25 | 3.29 | 3.155 | 1,306,720 |
| 2021-06-17 | 3.18 | 3.26 | 3.345 | 3.18 | 1,029,059 |
| 2021-06-16 | 3.16 | 3.22 | 3.22 | 3.08 | 1,601,989 |
| 2021-06-15 | 3.38 | 3.18 | 3.4 | 3.165 | 1,043,875 |
| 2021-06-14 | 3.3 | 3.4 | 3.4317 | 3.3 | 1,090,429 |
| 2021-06-11 | 3.31 | 3.28 | 3.33 | 3.21 | 1,334,766 |
| 2021-06-10 | 3.39 | 3.32 | 3.42 | 3.22 | 1,209,214 |
| 2021-06-09 | 3.44 | 3.38 | 3.49 | 3.36 | 1,320,208 |
| 2021-06-08 | 3.37 | 3.44 | 3.47 | 3.2 | 2,524,660 |
| 2021-06-07 | 2.9787 | 3.27 | 3.44 | 2.975 | 3,880,695 |
| 2021-06-04 | 2.95 | 2.94 | 3.03 | 2.9 | 913,648 |
| 2021-06-03 | 2.97 | 2.95 | 2.97 | 2.8301 | 1,470,571 |
| 2021-06-02 | 2.9 | 3 | 3.04 | 2.895 | 1,631,794 |
| 2021-06-01 | 2.86 | 2.86 | 2.92 | 2.81 | 999,971 |
| 2021-05-31 | 2.91 | 2.83 | 2.96 | 2.79 | 963,821 |
| 2021-05-28 | 2.91 | 2.83 | 2.96 | 2.79 | 961,861 |
Arbutus Biopharma Corporation Company Name:
ABUS Stock Symbol:
NASDAQ Market:
Arbutus Biopharma Corporation Website:
News, Short Squeeze, Breakout and More Instantly...
-
Conference Call and Webcast to discuss the new data being presented at EASL scheduled for 8:00 AM ET, Monday, June 28, 2021 WARMINSTER, Pa., June 02, 2021 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focus...
-
Image source: The Motley Fool. Arbutus Biopharma (NASDAQ: ABUS) Q1 2021 Earnings Call May 05, 2021 , 8:45 a.m. ET Operator Continue reading For further details see: Arbutus Biopharma (ABUS) Q1 2021 Earnings Call Transcript
-
AB-729, Arbutus’ proprietary subcutaneously delivered RNAi agent, continues to demonstrate robust and continuous declines in hepatitis B surface antigen (HBsAg) in subjects with chronic hepatitis B (HBV) with favorable safety and tolerability data Additional data from t...